
Princess of Wales Cancer Special Airs to Raise Funds
NBC's Nov. 30 broadcast sends all distribution proceeds to the Royal Marsden Cancer Charity.
Cancer coverage in the United States runs from research and approvals through to screening guidance and access to treatment. Reporting follows federal agencies, cancer centers and the trials running here.

NBC's Nov. 30 broadcast sends all distribution proceeds to the Royal Marsden Cancer Charity.
November 19, 2026
Marlon Jackson Discloses Stage Four Prostate CancerThe Jackson 5 member's account highlights how men can raise prostate cancer screening with their doctors.
November 18, 2026
Bill Would Make Breast Cancer Risk Checks RoutineWomen could see risk assessments become a standard part of care if the bipartisan Know Your Risk Act becomes law.
November 17, 2026
Jeff Ross Is Cancer-Free After Colon CancerAdults in midlife can be diagnosed with colon cancer without symptoms, so routine screening is worth discussing with your doctor.
November 9, 2026
Biden Says Cancer Treatment Limits Public ScheduleMen managing prostate cancer often face ongoing treatment that can change daily commitments, and Biden's update shows how that plays out publicly.
November 8, 2026
Coach's Son Starts Treatment for Hodgkin LymphomaJack McCaffery has taken indefinite leave from Richmond basketball while receiving care at Penn Medicine.
November 7, 2026
Nearly Half of Cancer Survivors Still Drink AlcoholA national survey found 45.8% of U.S. adults with a cancer history reported recent drinking in both 2016 and 2024.
November 7, 2026
1 in 3 Bladder Cancer Patients Wait Over 60 DaysIn a Columbia study, many patients waited more than two months for pre-surgery chemotherapy, often due to added testing and care transfers.
November 7, 2026
Ultrasound Trial Tests Chemo Boost for Pancreatic CancerPatients with borderline resectable or locally advanced pancreatic cancer are being enrolled in a trial combining focused ultrasound with chemotherapy.
November 7, 2026
New RAS-Targeted Drug Approved for Pancreatic CancerAdults whose pancreatic cancer has not responded to earlier treatment now have a first RAS-inhibitor option.
November 7, 2026
New CLL Drug Heads Toward 2027 FilingAdults with relapsed or refractory CLL may see a new targeted option after BeOne plans its accelerated-approval submission.
National reporting follows regulatory approvals and label changes, federal screening recommendations, research funding, and the coverage rules that determine what patients pay. It takes in the centers that deliver treatment and the workforce that staffs them, along with the places where care is hardest to reach. Approval and availability are treated separately, because a cleared therapy can take years to reach most patients. Coverage rules often decide which approved treatments patients can actually reach.